GCP
CABA icon

GSA Capital Partners’s Cabaletta Bio CABA Stock Holding History

GSA Capital Partners’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.51M Buy
561,726
+257,734
+85% +$716K 0.09% 279
2025
Q4 		$666K Buy
+303,992
New +$753K 0.06% 627
2024
Q4 		– Sell
-26,976
Closed -$127K – 1633
2024
Q3 		$127K Buy
+26,976
New +$156K 0.01% 1467
2023
Q3 		– Sell
-38,919
Closed -$502K – 1514
2023
Q2 		$502K Buy
+38,919
New +$422K 0.05% 730
2021
Q3 		– Sell
-33,753
Closed -$290K – 1449
2021
Q2 		$290K Buy
33,753
+22,253
+194% +$219K 0.03% 968
2021
Q1 		$128K Buy
+11,500
New +$140K 0.02% 978

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return